Biotherapies for Life TM Paul Perreault Chief Executive Officer and Managing Director, CSL Limited

First Page		Document Content
Date: 2013-10-31 13:44:37 Medicine Haemophilia CSL Behring Acute phase proteins Peripheral membrane proteins CSL Limited Recombinant proteins Emil Adolf von Behring Factor VIII Biology Blood Coagulation system		Biotherapies for Life TM Paul Perreault Chief Executive Officer and Managing Director, CSL Limited Add to Reading List Source URL: www.cslbehring.com Download Document from Source Website File Size: 3,78 MB Share Document on Facebook

	Gesellschaft für Technologietransfer mbH Success Stories of Preclinical Research between Academia and Industry DocID: 14dX5 - View Document
	Biotherapies for Life TM Paul Perreault Chief Executive Officer and Managing Director, CSL Limited DocID: 10xt9 - View Document
	Promoting Quality of Life Our employees know they perform a vital role in enhancing the lives of people across the globe. For example, our biotherapies prevent Rh-factor problems in newborns DocID: WUn5 - View Document
	CSL Limited Our Corporate Responsibility 2009 CSL Limited ABN[removed] DocID: TIjY - View Document
	Promoting Early Stage Researchers at Philipps-Universität Marburg Dr. Anne Holzapfel Marburg University Research Academy DocID: Oq4V - View Document